Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001477932-25-004921
Filing Date
2025-07-03
Accepted
2025-07-03 14:17:50
Documents
10

Document Format Files

Seq Description Document Type Size
1 FORM S-3 vnrx_s3.htm S-3 218080
2 SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION, AS AMENDED vnrx_ex31.htm EX-3.1 47477
3 DESCRIPTION OF CAPITAL STOCK vnrx_ex42.htm EX-4.2 15721
4 SECURITIES PURCHASE AGREEMENT, AS AMENDED vnrx_ex43.htm EX-4.3 234947
5 LEGAL OPINION OF STRADLING YOCCA CARLSON & RAUTH LLP vnrx_ex51.htm EX-5.1 11474
6 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM vnrx_ex231.htm EX-23.1 2025
7 FILING FEE TABLE vnrx_ex107.htm EX-FILING FEES 19948
8 vnrx_s3img2.jpg GRAPHIC 4881
9 vnrx_s3img1.jpg GRAPHIC 4702
10 vnrx_ex51img1.jpg GRAPHIC 3447
  Complete submission text file 0001477932-25-004921.txt   569139
Mailing Address 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014
Business Address 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014 1 (646) 650-1351
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

EIN.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-288508 | Film No.: 251105054
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)